Compassionate Use Study of 125 mg Per Day of Azimilide Dihydrochloride in One Patient

You may not be if

• Currently taking Class I or other Class III antiarrhythmic drug or other drugs that may prolong QT interval.
• Is unwilling or unable to give or understand informed consent.